Northern Trust Corp grew its stake in shares of TriMas Co. (NASDAQ:TRS - Free Report) by 9.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 398,213 shares of the industrial products company's stock after purchasing an additional 35,798 shares during the quarter. Northern Trust Corp owned approximately 0.98% of TriMas worth $9,792,000 at the end of the most recent quarter.
A number of other institutional investors have also recently made changes to their positions in the stock. Sterling Capital Management LLC raised its holdings in shares of TriMas by 815.5% during the fourth quarter. Sterling Capital Management LLC now owns 1,300 shares of the industrial products company's stock valued at $32,000 after acquiring an additional 1,158 shares in the last quarter. KLP Kapitalforvaltning AS bought a new position in shares of TriMas during the fourth quarter valued at approximately $202,000. Quantbot Technologies LP raised its holdings in shares of TriMas by 203.5% during the fourth quarter. Quantbot Technologies LP now owns 11,978 shares of the industrial products company's stock valued at $295,000 after acquiring an additional 8,031 shares in the last quarter. Aquatic Capital Management LLC bought a new position in shares of TriMas during the fourth quarter valued at approximately $359,000. Finally, MetLife Investment Management LLC raised its holdings in shares of TriMas by 5.9% during the fourth quarter. MetLife Investment Management LLC now owns 24,788 shares of the industrial products company's stock valued at $610,000 after acquiring an additional 1,378 shares in the last quarter. Hedge funds and other institutional investors own 99.42% of the company's stock.
Analyst Ratings Changes
Separately, BWS Financial restated a "buy" rating and set a $40.00 target price on shares of TriMas in a report on Wednesday, April 30th.
Check Out Our Latest Research Report on TRS
TriMas Trading Down 2.5%
Shares of TriMas stock traded down $0.66 during midday trading on Friday, reaching $25.42. 241,976 shares of the company's stock traded hands, compared to its average volume of 331,881. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.44 and a current ratio of 2.83. The company has a market cap of $1.03 billion, a PE ratio of 39.72 and a beta of 0.58. The stock has a 50 day moving average of $23.01 and a 200-day moving average of $24.07. TriMas Co. has a 12 month low of $19.33 and a 12 month high of $28.51.
TriMas (NASDAQ:TRS - Get Free Report) last announced its earnings results on Tuesday, April 29th. The industrial products company reported $0.46 EPS for the quarter, beating analysts' consensus estimates of $0.43 by $0.03. The company had revenue of $241.67 million during the quarter, compared to the consensus estimate of $235.41 million. TriMas had a return on equity of 9.21% and a net margin of 2.93%. The firm's revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.37 earnings per share. As a group, equities analysts expect that TriMas Co. will post 1.69 EPS for the current fiscal year.
TriMas Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, May 13th. Shareholders of record on Tuesday, May 6th were issued a $0.04 dividend. The ex-dividend date was Tuesday, May 6th. This represents a $0.16 dividend on an annualized basis and a yield of 0.63%. TriMas's dividend payout ratio (DPR) is 20.78%.
Insiders Place Their Bets
In related news, Director Jeffrey A. Fielkow bought 2,500 shares of the business's stock in a transaction dated Friday, February 28th. The shares were purchased at an average cost of $20.78 per share, with a total value of $51,950.00. Following the completion of the purchase, the director now owns 11,013 shares in the company, valued at approximately $228,850.14. The trade was a 29.37% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Shawn Sedaghat acquired 72,937 shares of the company's stock in a transaction that occurred on Thursday, May 22nd. The shares were acquired at an average cost of $26.16 per share, for a total transaction of $1,908,031.92. Following the completion of the transaction, the director now directly owns 1,883,758 shares of the company's stock, valued at $49,279,109.28. The trade was a 4.03% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders bought 1,772,695 shares of company stock worth $43,788,704. 14.20% of the stock is owned by corporate insiders.
TriMas Company Profile
(
Free Report)
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Featured Articles

Before you consider TriMas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.
While TriMas currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report